← Leaderboards
Kenneth S Rosenthal
Northeastern Ohio Universities Coll Med
$1,248,893
Attributed
$1,248,893
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,248,893 · 2
By mechanism
U01$1,102,893 · 1
R15$146,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Northeastern Ohio Universities Coll Med
Same institution · by research overlap
- William P Lynch$2,337,487
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseDrug Screening /EvaluationInfectious EncephalitisDrug Design /Synthesis /ProductionTissue /Cell CultureHerpes Simplex Virus 1Technology /Technique DevelopmentPharmacokineticsAlphavirusAnalogAntiviral AgentsBioassayCooperative StudyHerpes Simplex Virus 2ImmunomodulatorsProtein Structure FunctionNucleic Acid SequenceVaccine EvaluationVirus Infection MechanismVirus ProteinVirus Replication
Grant awards (4)
DerG (a new immunomodulator) Treatment of Viral Encepha*$439,070
U01 · FY2005 · AI
DerG (a new immunomodulator) Treatment of Viral Encepha*$329,378
U01 · FY2004 · AI
DerG (immunomodulator) Treatment of Viral Encephalitis$334,445
U01 · FY2003 · AI
FUNCTION AND ROLE OF HSV-1 ICP34.5 IN ENCEPHALITIS$146,000
R15 · FY2000 · NS